Abstract
An array of novel analogues of the marine oxylipins, the manzamenones and plakoridines, have been prepared in divergent fashion using an approach modelled on a biogenetic theory. Many of the target compounds show potent inhibition of DNA polymerases alpha and beta and human terminal deoxynucleotidyl transferase (TdT).
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Biological Products / chemical synthesis*
-
Biological Products / chemistry
-
Biological Products / pharmacology*
-
DNA Nucleotidylexotransferase / metabolism
-
DNA-Directed DNA Polymerase / metabolism
-
Enzyme Inhibitors / chemical synthesis*
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / pharmacology*
-
Humans
-
Molecular Structure
-
Nucleic Acid Synthesis Inhibitors*
-
Structure-Activity Relationship
Substances
-
Biological Products
-
Enzyme Inhibitors
-
Nucleic Acid Synthesis Inhibitors
-
DNA Nucleotidylexotransferase
-
DNA-Directed DNA Polymerase